Keywords: teva, lundbeck, boosted, pd, drug, pharmaceuticals, a/s

Teva and Lundbeck boosted on PD drug

Article | 12 April 2000

Print This

Teva Pharmaceuticals and H Lundbeck A/S have received a boost on newsthat they have completed Phase III clinical trials ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in